Replies to post #147040 on Biotech Values

[mcbio]

AH action in ARRY is benign. Last trade reported as 4.84

That's up 6%. I'll take that. Good quarter but it's certainly going to take much more concrete and positive clinical news or partnership news to move shares much higher I think.